Cartier M - Search Results

1

Serum creatinine and bilirubin predict renal failure and mortality in patients with spontaneous bacterial peritonitis: a retrospective study.

Terg R, Gadano A, Cartier M, Casciato P, Lucero R, Muñoz A, Romero G, Levi D, Terg G, Miguez C, Abecasis R. Terg R, et al. Among authors: cartier m. Liver Int. 2009 Mar;29(3):415-9. doi: 10.1111/j.1478-3231.2008.01877.x. Epub 2008 Sep 18. Liver Int. 2009. PMID: 18803587

2

Ciprofloxacin in primary prophylaxis of spontaneous bacterial peritonitis: a randomized, placebo-controlled study.

Terg R, Fassio E, Guevara M, Cartier M, Longo C, Lucero R, Landeira C, Romero G, Dominguez N, Muñoz A, Levi D, Miguez C, Abecasis R. Terg R, et al. Among authors: cartier m. J Hepatol. 2008 May;48(5):774-9. doi: 10.1016/j.jhep.2008.01.024. Epub 2008 Feb 14. J Hepatol. 2008. PMID: 18316137 Clinical Trial.

3

Prevalence of primary sclerosing cholangitis in patients with ulcerative colitis and the risk of developing malignancies. A large prospective study.

Terg R, Sambuelli A, Coronel E, Mazzuco J, Cartier M, Negreira S, Muñoz A, Gil A, Miguez C, Huernos S, Romero G, Goncalvez S, Levi D, Abecasis R. Terg R, et al. Among authors: cartier m. Acta Gastroenterol Latinoam. 2008 Mar;38(1):26-33. Acta Gastroenterol Latinoam. 2008. PMID: 18533354

4

Pilot study: Gelafundin (polygeline) 4% plus antibiotics in the treatment of high-risk cirrhotic patients with spontaneous bacterial peritonitis.

Cartier M, Terg R, Lucero R, Muñoz A, Romero G, Levi D, Miguez C, Abecasis R. Cartier M, et al. Aliment Pharmacol Ther. 2010 Jul;32(1):43-8. doi: 10.1111/j.1365-2036.2010.04309.x. Epub 2010 Mar 23. Aliment Pharmacol Ther. 2010. PMID: 20345510

5

Proton pump inhibitor therapy does not increase the incidence of spontaneous bacterial peritonitis in cirrhosis: a multicenter prospective study.

Terg R, Casciato P, Garbe C, Cartier M, Stieben T, Mendizabal M, Niveyro C, Benavides J, Marino M, Colombato L, Berbara D, Silva M, Salgado P, Barreyro F, Fassio E, Gadano A; Study Group of Cirrhosis Complications of the Argentine Association for the Study of Liver Disease. Terg R, et al. Among authors: cartier m. J Hepatol. 2015 May;62(5):1056-60. doi: 10.1016/j.jhep.2014.11.036. Epub 2014 Dec 4. J Hepatol. 2015. PMID: 25481567

6

Immune dysfunction in cirrhosis: Distinct cytokines phenotypes according to cirrhosis severity.

Dirchwolf M, Podhorzer A, Marino M, Shulman C, Cartier M, Zunino M, Paz S, Muñoz A, Bocassi A, Gimenez J, Di Pietro L, Romero G, Fainboim H, Fainboim L. Dirchwolf M, et al. Among authors: cartier m. Cytokine. 2016 Jan;77:14-25. doi: 10.1016/j.cyto.2015.10.006. Epub 2015 Oct 23. Cytokine. 2016. PMID: 26517154

7

[Adrenal insufficiency in cirrhotic patients].

Orozco F, Anders M, Mella J, Antinucci F, Pagano P, Esteban P, Cartier M, Romero G, Francini B, Mastai R. Orozco F, et al. Among authors: cartier m. Medicina (B Aires). 2016;76(4):208-12. Medicina (B Aires). 2016. PMID: 27576278 Free article. Spanish.

8

Ombitasvir/paritaprevir/ritonavir/dasabuvir ± ribavirin is safe and effective in HCV-infected patients in a real-life cohort from Latin America.

Mendizabal M, Haddad L, Gallardo PE, Ferrada A, Soza AA, Adrover R, Aravena E, Roblero JP, Prieto J, Vujacich C, Romero G, Muñoz A, Anders M, Hernández N, Coccozella D, Gruz F, Reggiardo MV, Ruf AE, Varón A, Cartier M, Pérez Ravier R, Ridruejo E, Peralta M, Poncino D, Vorobioff J, Aballay Soteras G, Silva MO. Mendizabal M, et al. Among authors: cartier m. J Med Virol. 2017 Sep;89(9):1590-1596. doi: 10.1002/jmv.24816. Epub 2017 Jun 6. J Med Virol. 2017. PMID: 28370222

9

Effectiveness and safety of original and generic sofosbuvir for the treatment of chronic hepatitis C: A real world study.

Marciano S, Haddad L, Reggiardo MV, Peralta M, Vistarini C, Marino M, Descalzi VI, D'Amico C, Figueroa Escuti S, Gaite LA, Perez Ravier R, Longo C, Borzi SM, Galdame OA, Bessone F, Fainboim HA, Frías S, Cartier M, Gadano AC. Marciano S, et al. Among authors: cartier m. J Med Virol. 2018 May;90(5):951-958. doi: 10.1002/jmv.25033. Epub 2018 Feb 15. J Med Virol. 2018. PMID: 29350402

10

Safety of Chronic Simvastatin Treatment in Patients with Decompensated Cirrhosis: Many Adverse Events but No Liver Injury.

Muñoz AE, Pollarsky F, Marino M, Cartier M, Míguez C, Vázquez H, Álvarez D, Salgado P, Romero G. Muñoz AE, et al. Among authors: cartier m. Dig Dis Sci. 2021 Sep;66(9):3199-3208. doi: 10.1007/s10620-020-06630-7. Epub 2020 Oct 9. Dig Dis Sci. 2021. PMID: 33033975 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

70 results

Search Page

Filters